MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis. (Q53341906)

From Wikidata
Jump to navigation Jump to search
scientific article published in September 2006
edit
Language Label Description Also known as
English
MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis.
scientific article published in September 2006

    Statements

    MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit